Similar articles

• TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism.

  Shepard CR. Shepard CR. Front Endocrinol (Lausanne). 2021 Jan 29;11:613639. doi: 10.3389/fendo.2020.613639. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33584545 Free PMC article. Review.
• Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?

  Handa P, Vemulakonda A, Kowdley KV, Uribe M, Méndez-Sánchez N. Handa P, et al. World J Gastroenterol. 2016 Aug 21;22(31):6965-71. doi: 10.3748/wjg.v22.i31.6965. World J Gastroenterol. 2016. PMID: 27610009 Free PMC article.
• TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.

  Mridha AR, Haczeyni F, Yeh MM, Haigh WG, Ioannou GN, Barn V, Ajamieh H, Adams L, Hamdorf JM, Teoh NC, Farrell GC. Mridha AR, et al. Clin Sci (Lond). 2017 Jul 24;131(16):2145-2159. doi: 10.1042/CS20160838. Print 2017 Aug 15. Clin Sci (Lond). 2017. PMID: 28687713
• Hepatocyte mitochondrial DNA released in microparticles and toll-like receptor 9 activation: A link between lipotoxicity and inflammation during nonalcoholic steatohepatitis.

  Inzaugarat ME, Wree A, Feldstein AE. Inzaugarat ME, et al. Hepatology. 2016 Aug;64(2):669-71. doi: 10.1002/hep.28666. Epub 2016 Jun 24. Hepatology. 2016. PMID: 27239763 Free PMC article. No abstract available.
• The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).

  Nati M, Haddad D, Birkenfeld AL, Koch CA, Chavakis T, Chatzigeorgiou A. Nati M, et al. Rev Endocr Metab Disord. 2016 Mar;17(1):29-39. doi: 10.1007/s11154-016-9339-2. Rev Endocr Metab Disord. 2016. PMID: 26847547 Review.